AAP
CGEN icon

Arax Advisory Partners’s Compugen CGEN Stock Holding History

Arax Advisory Partners’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Hold
131,800
– – ﹤0.01% 2008
2026
Q1 		$281K Buy
+131,800
New +$256K 0.01% 907

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

Arax Advisory Partners's CGEN Position: Q2 2026 in Review

Arax Advisory Partners held its Compugen (CGEN) position steady in Q2 2026 at 131,800 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Arax Advisory Partners first reported a position in CGEN in Q1 2026 and has held it in 2 quarters since. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Arax Advisory Partners held 131,800 shares of Compugen worth $282K as of Q2 2026.
  • Arax Advisory Partners left its Compugen share count unchanged in Q2 2026.
  • Compugen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2008 holding.
  • Arax Advisory Partners first reported a position in Compugen in Q1 2026 and has held it in 2 quarters since.
  • 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.